It has been reported that adiponectin deficient mice develop hepatosteatosis whereas elevation of adiponectin levels in circulation through pharmacological and genetic approaches protect mice from developing obesity-related hepatosteatosis [35], [36]. This evidence concerns the gene ADIPOQ and obesity disorder.